Alameda Healthcare Group, one of Egypt’s leading private healthcare providers, and Siemens Healthineers have strengthened their strategic partnership to advance the future of oncology care in Egypt through precision medicine, innovative medical technologies, and integrated healthcare solutions.
The two organizations hosted the strategic gathering “Leading the Future of Oncology with Precision and Partnership,” bringing together healthcare leaders, business partners, industry stakeholders, physicians, and academic experts to discuss the future of cancer care in Egypt and highlight the importance of collaboration in transforming healthcare delivery.
Strategic Partnership to Enhance Cancer Care and Patient Outcomes
Held at Giza Palace Hotel, the event showcased the latest advancements in oncology services at Dar Al Fouad Hospitals, including patient-centered treatment models designed to improve clinical outcomes and enhance the overall patient experience.
The gathering highlighted the growing role of strategic partnerships, particularly the collaboration between Alameda Healthcare Group and Siemens Healthineers, in advancing cancer treatment through precision medicine, advanced technologies, and data-driven healthcare solutions.
The event brought together representatives from the healthcare, insurance, and banking sectors, alongside leading physicians and academic experts, emphasizing the importance of cross-sector collaboration in building a more integrated, resilient, and future-ready healthcare ecosystem in Egypt.
Dar Al Fouad Hospital Introduces TrueBeam® Advanced Radiotherapy System
As part of the shared commitment to healthcare innovation, the event coincided with the inauguration of the TrueBeam® radiotherapy system from Siemens Healthineers at Dar Al Fouad Hospital – 6th of October.
The introduction of this advanced technology represents a significant milestone in the hospital’s ongoing efforts to expand access to state-of-the-art cancer treatment solutions.
The TrueBeam® system is an advanced linear accelerator designed to deliver highly precise, image-guided radiation therapy for a wide range of cancer types. The system combines exceptional treatment accuracy with faster delivery, advanced motion management, and enhanced tumor targeting capabilities.
By enabling clinicians to precisely target tumors while minimizing radiation exposure to surrounding healthy tissues, TrueBeam® supports more efficient treatment procedures, shorter therapy sessions, improved patient comfort, and better clinical outcomes.
Dar Al Fouad Strengthens Its Leadership in Specialized Oncology Care
As one of Egypt’s leading healthcare institutions, Dar Al Fouad Hospitals continues to enhance specialized medical services through clinical excellence, patient-focused treatment models, and continuous investment in innovation.
The hospital has provided healthcare services to more than five million patients, including over 100,000 cancer patients treated during the past five years. It has also invested more than EGP 350 million in advanced medical technologies and operates with a capacity exceeding 200 beds.
Dar Al Fouad was also the first hospital in Egypt to receive Joint Commission International (JCI) accreditation, reflecting its commitment to international standards of healthcare quality and patient safety.
Alameda Accelerates Oncology Innovation Through Technology and Integrated Care
The collaboration with Siemens Healthineers reinforces Alameda Healthcare Group’s commitment to accelerating innovation in oncology care by leveraging advanced technologies, digital healthcare solutions, data-driven insights, and integrated treatment models.
The partnership aims to improve clinical outcomes, expand access to specialized cancer treatments, and support the development of a comprehensive oncology ecosystem in Egypt.
Alameda: Building the Future of Precision Oncology Care
Commenting on the partnership, Neeraj Mishra, Group Chief Executive Officer of Alameda Healthcare Group, said:
“At Alameda Healthcare Group, we believe the future of healthcare lies in building integrated centers of excellence that combine world-class clinical expertise, advanced technology, and research-driven innovation.”
Mishra emphasized that oncology represents a strategic priority within Alameda’s long-term growth and expansion strategy, as the group continues investing in specialized capabilities to redefine cancer care in Egypt and the region.
He added that the partnership with Siemens Healthineers extends beyond introducing advanced technologies, representing a commitment to creating a comprehensive oncology ecosystem that integrates precision medicine, multidisciplinary care, and digital innovation to improve patient outcomes.
He further highlighted that Alameda remains focused on delivering internationally benchmarked healthcare services while expanding access to advanced cancer treatments across the communities it serves.
Dar Al Fouad: Advanced Technologies Supporting Personalized Cancer Treatment
Naveen Goel, Chief Executive Officer of Dar Al Fouad Hospital – 6th of October, stated that oncology care is rapidly evolving and achieving the best clinical outcomes requires seamless integration between advanced technologies, multidisciplinary expertise, and compassionate patient-centered care.
He emphasized Dar Al Fouad’s continued efforts to strengthen its oncology capabilities and provide personalized treatment pathways based on the highest international standards, ensuring that every patient receives precise, evidence-based care throughout their treatment journey.
Siemens Healthineers Reinforces Long-Term Healthcare Innovation Partnership
Amro Kandil, Managing Director of Siemens Healthineers Egypt, highlighted the longstanding collaboration between Siemens Healthineers and Alameda Healthcare Group, which has extended for more than two decades in delivering world-class healthcare solutions across multiple medical specialties in Egypt.
He explained that introducing the TrueBeam® radiotherapy system at Dar Al Fouad Hospital marks an important milestone in this partnership, expanding access to advanced cancer treatment technologies and reinforcing both organizations’ commitment to innovative, patient-centered healthcare.
Kandil added that Siemens Healthineers and Alameda look forward to continuing their collaboration and achieving further milestones in advancing healthcare services in Egypt.
Strengthening Egypt’s Position as a Regional Healthcare Hub
The partnership between Alameda Healthcare Group and Siemens Healthineers reflects the growing role of strategic collaboration in shaping the future of healthcare in Egypt.
By combining medical expertise, advanced technologies, and innovation-driven solutions, the partnership contributes to expanding access to specialized treatments and supporting the long-term sustainability of the healthcare sector.
The collaboration further strengthens Egypt’s position as a regional hub for advanced medical services and healthcare innovation.
About Alameda Healthcare Group
Alameda Healthcare Group is a leading healthcare provider in Egypt, committed to delivering high-quality medical services through advanced technologies, international partnerships, and patient-centered care models.
The group operates a network with a capacity of 1,023 beds and 128 clinics across four internationally accredited facilities in Greater Cairo, including As-Salam International Hospital – Maadi, As-Salam International Hospital – New Cairo, Dar Al Fouad Hospital – Nasr City, and Dar Al Fouad Hospital – 6th of October.
The group also operates Elixir, a specialized outpatient endoscopy center located in Mohandessin and Maadi, the German Rehabilitation Center, and Tabibi, a 24/7 primary healthcare clinic network located in Downtown, Fifth Settlement, Maadi, and 6th of October.
About Siemens Healthineers
Siemens Healthineers is a global leader in medical technology, dedicated to enabling healthcare providers to deliver better outcomes for patients worldwide.
The company provides healthcare equipment, solutions, and services across more than 180 countries, with direct representation in more than 70 countries.
Its key areas of expertise include medical imaging, diagnostics, cancer care, minimally invasive therapies, digital healthcare technologies, and artificial intelligence solutions.
During fiscal year 2024, Siemens Healthineers employed approximately 72,000 people worldwide and generated revenues of approximately €22.4 billion.
